Among the genes found exclusively in the good responder group, COL12A1 upregulation has been identified as a predictor of poor prognosis in human patients with pancreatic adenocarcinoma [30] and gastric cancer [31]. This evidence concerns the gene COL12A1 and gastric cancer.